| 2017 | | Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma | 김순선, 김진우, 노충균, 신성재, 양민재, 원제환, 이기명, 정재연, 조성원, 조효정, 지재훈 |
| 2018 | | Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma | 김보현, 김순선, 김재근, 김진우, 김현지, 원제환, 이제희, 정재연, 조성원, 조효정 |
| 2022 | | Prediction of Decompensation and Death in Advanced Chronic Liver Disease Using Deep Learning Analysis of Gadoxetic Acid-Enhanced MRI | 허수빈 |
| 2016 | | Quantitative Assessment of the Portal Pressure for the Liver Surgery Using Serological Tests | 김봉완, 김영배, 김진우, 심주현, 왕희정, 원제환 |
| 2021 | | Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid–enhanced MRI in at-risk patients | 허지미 |
| 2022 | | Risk Prediction Model Based on Magnetic Resonance Elastography-Assessed Liver Stiffness for Predicting Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma | 김봉완, 김순선, 김재근, 은정우, 이제희, 정재연, 조효정, 허지미 |
| 2014 | | Stereotactic body radiotherapy-induced arterial hypervascularity of non-tumorous hepatic parenchyma in patients with hepatocellular carcinoma: potential pitfalls in tumor response evaluation on multiphase computed tomography. | 박미진 |
| 2018 | | The capsule appearance of hepatocellular carcinoma in gadoxetic acid-enhanced MR imaging: Correlation with pathology and dynamic CT | 김보현, 김영배, 김재근, 김혜진, 이다근, 이제희 |
| 2007 | | Transcatheter arterial chemoembolization of hepatocellular carcinoma with hepatic arteriovenous shunt after temporary balloon occlusion of hepatic vein. | 원제환 |
